By merging capabilities, the alliance will enable the life sciences industry to utilise scientific AI to develop advanced therapies. Credit: metamorworks / Shutterstock.com.

TetraScience has formed a strategic partnership with Google Cloud to expedite the development of drugs and other scientific advancements leveraging AI.

The collaboration uses the Tetra Scientific Data and AI Cloud alongside the infrastructure and AI capabilities of Google Cloud to enable the life sciences industry to utilise scientific AI for rapid insight generation.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

This approach expedites and enhances research, development and quality-control works linked to advanced therapies. 

By consolidating and streamlining the production of large-scale, AI-native scientific data sets, the Tetra Scientific Data and AI Cloud intends to break through the common data silo issue.

These datasets are utilised in an expanding array of lab data management products, scientific applications and AI-driven results, supporting scientists, data and AI teams, and IT organisations.

Scientists can work more efficiently and push the boundaries of innovation.

Data and AI specialists will have access to AI-ready datasets and integrated tools to facilitate scientific AI outcomes.

Scientific IT teams will also benefit from the alliance and could see reduced costs and a smoother transition into the future.

Ginkgo Bioworks CTO Barry Canton stated: “The Tetra Scientific Data and AI Cloud, combined with the power of Google Cloud’s AI services, gives researchers a robust and accessible platform and technology to collaborate, innovate and ultimately create revolutionary products.

“We look forward to seeing what this partnership can do to help accelerate drug discovery and development.”

Ginkgo Bioworks is a client of TetraScience and Google Cloud. It is developing a platform for cell programming and biosecurity.

Google Cloud Healthcare and Life Sciences managing director Ryan Terry stated: “Science is often slowed down by fragmented data and inefficient workflows. This collaboration addresses these roadblocks, giving life science organisations the practical tools they need to accelerate drug discovery and development to bring life-changing treatments to patients sooner.

“By combining Google Cloud’s data and AI capabilities with TetraScience’s proven domain expertise across scientific data and associated use cases, we hope to empower scientists to find solutions to some of our most pressing health challenges faster than ever before.”

The latest development comes shortly after Google Cloud announced a partnership with Bayer to expedite the development of AI-powered solutions for radiologists.